{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:42:02Z","timestamp":1770914522077,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Reducing the risk of renal scarring in infants with urinary tract infection (UTI) necessitates timely and effective administration of antimicrobial treatment. The Israeli Medical Association recommends the empirical use of gentamicin and ampicillin for febrile infants younger than 2 months with suspected UTI. We aimed to assess the prevalence of Extended Spectrum Beta-Lactamase (ESBL)-producing and gentamicin-resistant Gram-negative UTI among infants younger than 2 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A multicenter retrospective cross-sectional study of infants younger than 2 months with UTI who visited Clalit Health Services pediatric emergency departments between January 1, 2016, and December 31, 2021. The primary outcome measure was the prevalence of ESBL-associated and gentamicin-resistant UTI. The secondary outcome measure was the factors associated with such resistant bacteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 1142 infants were included. Sixty-five (5.7%) and 64 (5.6%) infants had gentamicin-resistant and ESBL-producing Gram-negative UTI, respectively. Forty-two percent of ESBL-associated UTI were gentamicin-resistant. Higher ESBL rates were found during first week of life (14.8% versus 4.1%\u20137.7%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.009). Similarly, higher rates of gentamicin resistance were found in this age group (11.2%). Admission rate to pediatric intensive care units (ICUs) was higher in infants with ESBL-associated UTI (9.8% versus 3.5%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.015). Gestational bacteriuria, previous neonatal ICU admission or gender were not associated with either gentamicin or ESBL-producing resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our findings support the current recommendations for empirical intravenous treatment. However, modification of the treatment protocol should be considered for infants younger than 7 days, who had higher rates of ESBL-producing and gentamicin-resistant Gram-negative UTI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003977","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:01:18Z","timestamp":1685563278000},"page":"750-753","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["High Rates of ESBL-producing and Gentamycin-resistant Gram-negative Bacteria During the First Week of Life: A Multicenter Cross-sectional Study Among Infants Younger Than 2 Months With Urinary Tract Infection"],"prefix":"10.1097","volume":"42","author":[{"given":"Muhammad","family":"Washahi","sequence":"first","affiliation":[{"name":"Pediatric Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Miron","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease Unit, Ha\u2019Emek Medical Center, Afula"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Steinberg Ben Zeev","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease Unit, Ha\u2019Emek Medical Center, Afula"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Chayen","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-1120","authenticated-orcid":false,"given":"Ron","family":"Jacob","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department"},{"name":"Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00467-014-2810-y","article-title":"Extended-spectrum \u03b2-lactamase-producing bacteria causing community-acquired urinary tract infections in children.","volume":"29","author":"Megged","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"e2020012138","DOI":"10.1542\/peds.2020-012138","article-title":"Contemporary management of urinary tract infection in children.","volume":"147","author":"Mattoo","year":"2021","journal-title":"Pediatrics"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/INF.0b013e31815e4122","article-title":"Prevalence of urinary tract infection in childhood: a meta-analysis.","volume":"27","author":"Shaikh","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamapediatrics.2016.1181","article-title":"Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring.","volume":"170","author":"Shaikh","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jinf.2016.07.014","article-title":"Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: a systematic review and meta-analysis.","volume":"73","author":"Flokas","year":"2016","journal-title":"J Infect"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/apa.14889","article-title":"Nationwide epidemiology of early-onset sepsis in Israel 2010-2015, time to re-evaluate empiric treatment.","volume":"108","author":"Glikman","year":"2019","journal-title":"Acta Paediatr"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/INF.0000000000001373","article-title":"Antimicrobial resistance among uropathogens that cause childhood community-acquired urinary tract Infections in Central Israel.","volume":"36","author":"Yakubov","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/apa.13322","article-title":"Infants under two months of age with urinary tract infections are showing increasing resistance to empirical and oral antibiotics.","volume":"105","author":"Segal","year":"2016","journal-title":"Acta Paediatr"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0009922814555974","article-title":"Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. a comparison between first episode and recurrent infection.","volume":"54","author":"Sakran","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e0190910","DOI":"10.1371\/journal.pone.0190910","article-title":"Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing enterobacteriaceae in children: a French prospective multicenter study.","volume":"13","author":"Madhi","year":"2018","journal-title":"PLoS One"},{"key":"R15-20250614","first-page":"907","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae among pregnant women in Norway: prevalence and maternal-neonatal transmission.","volume":"35","author":"Rettedal","year":"2015","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/microorganisms9061245","article-title":"Mother-to-Neonate transmission of antibiotic-resistant bacteria: a cross-sectional study.","volume":"9","author":"Matok","year":"2021","journal-title":"Microorganisms"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon.","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3345\/kjp.2012.55.10.367","article-title":"Renal scar formation after urinary tract infection in children.","volume":"55","author":"Park","year":"2012","journal-title":"Korean J Pediatr"},{"key":"R18-20250614","first-page":"928","article-title":"What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review.","volume":"28","author":"Auzin","year":"2022","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:06:36Z","timestamp":1749945996000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003977","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,29]]}}}